Sessa, C <br/><br/>
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2007 
 - 561-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Camptothecin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Europe<br/>Female<br/>Half-Life<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Treatment Outcome